<DOC>
	<DOC>NCT00038532</DOC>
	<brief_summary>The purpose of this study is to study amprenavir/ritonavir, saquinavir/ritonavir or efavirenz in HIV-infected patients following failure with Kaletra (ABT-378/ritonavir) as their first protease inhibitor based HAART.</brief_summary>
	<brief_title>Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Lopinavir</mesh_term>
	<mesh_term>HIV Protease Inhibitors</mesh_term>
	<mesh_term>Saquinavir</mesh_term>
	<mesh_term>Amprenavir</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Inclusion: Remain on present antiHIV drugs during screening until a new regimen is started. Have a viral load of at least 1,000 copies/ml on the 2 most recent tests after at least 24 weeks of lopinavir/ritonavir and while still on it. Have an HIV which shows reduced susceptibility to lopinavir. Are at least 18 years old. Are not presently ill. Have not been treated for an opportunistic infection within 30 days of screening. Agree not to take certain drugs and agree to inform and get permission from the doctor before taking any medicines, over the counter medicines, herbal medicines, alcohol or recreational drugs. Agree to use an accepted barrier method of birth control. Exclusion: Female subject is pregnant or lactating. Have taken any protease inhibitor other than lopinavir/ritonavir for more that two weeks. Are taking chemotherapy. Have a medical problem with their pancreas. Have been screened for this study within the past 12 weeks. Appear to be unsuitable in the opinion of the doctor.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2006</verification_date>
	<keyword>treatment experienced</keyword>
	<keyword>HIV</keyword>
</DOC>